secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2026-02-10T23:59:59+00:00
Accession:  0001493152-26-005840
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Calidi Biotherapeutics posts updated corporate presentation; details unknown
----------------------------------------------------------------------------

- Company made updated presentation available on its website on February 6, 2026.
- Presentation furnished as Exhibit 99.1 to this Form 8-K under Item 7.01 Regulation FD.
- No specific financial or operational updates disclosed in the filing excerpt provided.
- Presentation content not included in the available text; cannot assess material changes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000149315226005840/0001493152-26-005840-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000149315226005840/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-005840

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer